Wolfe Research Reiterates Outperform Rating on AnaptysBio (ANAB)

August 31, 2026 5:37 AM EDT Send to a Friend
Wolfe Research analyst Andy Chen reiterated an Outperform rating and $78.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst comments "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login